Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open
November 15, 2021 14:38 ET | Eyenuk, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
eyenuk_logo_redesign_2017_onecolor.png
Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology
November 04, 2021 17:09 ET | Eyenuk, Inc.
LOS ANGELES, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
eyenuk_logo_redesign_2017_onecolor.png
Eyenuk Reports Strong 2021 Business Growth
May 12, 2021 11:00 ET | Eyenuk, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
National Coalition Launches new scEYEnce Campaign
September 09, 2020 09:00 ET | scEYEnce
—Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being—NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- A national coalition of 10 leading...
5c7ec11d9645b30004db9101_1.png
ADM Tronics to Develop Patented, Next-Generation Ophthalmic Diagnostic System for RetinalGeniX Technologies, Inc.
January 13, 2020 09:54 ET | ADM Tronics Unlimited, Inc.
Northvale, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that RetinalGeniX Technologies, Inc. (“RTI”), has entered into an engineering...
Retinal Disease Therapeutics Market to Reach US$ 21,318.0 Mn by 2026, Advancements in Retinal Disease Diagnosis Devices to Boost the Market, says Fortune Business Insights
July 12, 2019 06:44 ET | Fortune Business Insights
Pune, July 12, 2019 (GLOBE NEWSWIRE) -- The global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards prevention and...
RND logo.PNG
Diabetic Retinopathy Market to Reach USD 13.04 billion By 2026 | Reports And Data
June 06, 2019 12:30 ET | Reports And Data
Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the dread of losing vision have augmented the...
Rise of Diabetes Epidemic Leads to Innovations in Diabetic Patient Care Nationwide
November 06, 2017 08:30 ET | Vision Source
Kingwood, Texas, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The 2017 National Diabetes Statistics Report, published by the Centers for Disease Control and Prevention, found that 30.3 million people are...
Diabetic Retinopathy Market by Type and Management - Global Industry Analysis and Forecast To 2025
October 18, 2017 05:19 ET | Crystal Market Research
LAS VEGAS, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The global Diabetic Retinopathy Market is projected to be around $2.6 billion by 2025. This growth can be attributed to increase in prevalence of...
Diabetic Retinopathy Market size to exceed $11 Billion by 2023: Global Market Insights, Inc.
June 14, 2016 07:00 ET | Global Market Insights
Delaware, June 14, 2016 (GLOBE NEWSWIRE) -- Diabetic Retinopathy Market size is projected to reach USD 11.1 billion by 2023; as per a new research report by Global Market Insights, Inc. rising...